Latest Stories
DXC’s (NYSE:DXC) Q4 CY2025 Earnings Results: Revenue In Line With Expectations
IT services provider DXC Technology (NYSE:DXC) met Wall Streets revenue expectations in Q4 CY2025, but sales were flat year on year at $3.19 billion. On the other hand, next quarter’s revenue guidance of $3.18 billion was less impressive, coming in 1% below analysts’ estimates. Its non-GAAP profit of $0.96 per share was 16.2% above analysts’ consensus estimates.
Selective Insurance Group’s (NASDAQ:SIGI) Q4 CY2025 Earnings Results: Revenue In Line With Expectations
Property and casualty insurer Selective Insurance Group (NASDAQ:SIGI) met Wall Streets revenue expectations in Q4 CY2025, with sales up 8.6% year on year to $1.36 billion. Its non-GAAP profit of $2.57 per share was 17.7% above analysts’ consensus estimates.
PennyMac Financial Services (NYSE:PFSI) Misses Q4 CY2025 Revenue Estimates, Stock Drops 22.5%
Mortgage banking company PennyMac Financial Services (NYSE:PFSI) missed Wall Street’s revenue expectations in Q4 CY2025, with sales flat year on year at $538 million. Its GAAP profit of $1.97 per share was 39.6% below analysts’ consensus estimates.
Federated Hermes’s (NYSE:FHI) Q4 CY2025: Beats On Revenue
Investment management firm Federated Hermes (NYSE:FHI) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 13.7% year on year to $482.8 million. Its GAAP profit of $1.39 per share was 14% above analysts’ consensus estimates.
Axos Financial (NYSE:AX) Delivers Strong Q4 CY2025 Numbers
Digital banking company Axos Financial (NYSE:AX) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 25.1% year on year to $385.1 million. Its non-GAAP profit of $2.25 per share was 8.5% above analysts’ consensus estimates.
Deckers (NYSE:DECK) Reports Strong Q4 CY2025, Stock Jumps 13.1%
Footwear and apparel conglomerate Deckers (NYSE:DECK) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 7.1% year on year to $1.96 billion. The company’s full-year revenue guidance of $5.41 billion at the midpoint came in 0.9% above analysts’ estimates. Its GAAP profit of $3.33 per share was 20.5% above analysts’ consensus estimates.
Visa (NYSE:V) Posts Better-Than-Expected Sales In Q4 CY2025
Global payments technology company Visa (NYSE:V) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 14.6% year on year to $10.9 billion. Its non-GAAP profit of $3.17 per share was 0.9% above analysts’ consensus estimates.
ResMed (NYSE:RMD) Exceeds Q4 CY2025 Expectations
Medical device company ResMed (NYSE:RMD) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 11% year on year to $1.42 billion. Its non-GAAP profit of $2.81 per share was 3.2% above analysts’ consensus estimates.
Seacoast Banking’s (NASDAQ:SBCF) Q4 CY2025 Sales Beat Estimates
Florida regional bank Seacoast Banking (NASDAQ:SBCF) announced better-than-expected revenue in Q4 CY2025, with sales up 43.6% year on year to $203.3 million. Its non-GAAP profit of $0.44 per share was 11.7% below analysts’ consensus estimates.
Stryker’s (NYSE:SYK) Q4 CY2025 Sales Top Estimates
Medical technology company Stryker (NYSE:SYK) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.4% year on year to $7.17 billion. Its non-GAAP profit of $4.47 per share was 1.7% above analysts’ consensus estimates.